Filing Details
- Accession Number:
- 0000909012-12-000273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-14 15:19:50
- Reporting Period:
- 2012-05-11
- Filing Date:
- 2012-05-14
- Accepted Time:
- 2012-05-14 14:19:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897075 | Repros Therapeutics Inc. | RPRX | Biological Products, (No Disgnostic Substances) (2836) | 760233274 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1164426 | Joseph Edelman | Perceptive Advisors Llc 499 Park Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No | |
| 1224962 | Perceptive Advisors Llc | 499 Park Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No | |
| 1249675 | Ltd Fund Master Sciences Life Perceptive | C/O Perceptive Advisors Llc 499 Park Avenue, 25Th Floor New York NY 10022 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-05-11 | 145,000 | $6.35 | 2,778,060 | No | 4 | P | Indirect | See Footnotes |
| Common Stock | Acquisiton | 2012-05-11 | 25,000 | $6.35 | 2,803,060 | No | 4 | P | Indirect | See Footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnotes |
| No | 4 | P | Indirect | See Footnotes |
Footnotes
- This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as investment manager to the Master Fund. Mr. Edelman is the managing member of the Advisor.
- This amount reflects the total amount of securities held by the Master Fund immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by the Master Fund is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
Billionaire Hedge Funds
